Deinove signs a collaboration agreement with the Tereos group
Deinove announced the signature of a collaboration agreement with BENP Lillebonne, in partnership with Syral (both subsidiaries of the agro-industrial group Tereos). The agreement covers the industrial validation of innovative processes developed by Deinove for the production of ethanol via fermentation of feed grain.
Deinove will retain the worldwide rights to exploitation of its technologies and BENP Lillebonne will receive a license for industrial application. The goal is to achieve high-performance, cost-effective ethanol production. The agreement forms part of the €21.4 million Deinol project, which has notably received €8.9 million in funding from the Strategic Industrial Innovation programme run by the French state innovation agency OSEO.
As Project Leader, Deinove will receive €6 million in funding. The Deinol project's goal is to open up (by 2014) new pathways for lignocellulosic ("second-generation") ethanol production in existing industrial installations and without the need for massive additional investment.
"This major agreement demonstrates that the breakthrough technologies based on our 'bacterial cell factories' are rooted in industrial reality", emphasized Deinove CEO Jacques Biton. He added, "The perfect fit between Deinove and Tereos maximizes our chances of success, from R&D through to worldwide commercial operation".
"The deinococci appear to be capable of achieving significant productivity gains. In particular, the enzymatic properties of certain strains has prompted us to envisage exploitation of the hemicellulose and cellulose in fermentation wort and thus improve yields in cereal-based ethanol production. That would be an important milestone on the way to second-generation, 100% lignocellulosic production", commented Anne Wagner, Innovation Director at SYRAL.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Carl Zeiss Ltd. acquires Imaging Associates Ltd.
DOE JGI decodes DNA of growth-promoting fungus

A new form of light - Scientists have discovered a method to create fluorescent light that may have promising applications

Mechanism that causes cell nuclei to grow discovered

Bioscreen Instruments Pvt. Ltd. - Chennai, India
BioSource International, Inc. Named to Deloitte's "Technology Fast 50'' Program
Symphogen and Swedish Orphan Biovitrum receive U.S. orphan drug designation for Rozrolimupab in ITP
